Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03803059 · ClinicalTrials.gov registry record · NA

Efficacy and Tolerability of SkinPen on Male and Female Subjects' Wrinkles of the Neck

A NA study, sponsored by Bellus Medical.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT03803059 is a NA study that has completed, run by Bellus Medical. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03803059, a NA study, has completed, sponsored by Bellus Medical.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

This single-center, the clinical trial is being conducted over the course of 90 days followed by 1-month and 6-month post-treatment visits in order to assess the efficacy and tolerability of the Sponsor's SkinPen device when used by men and women with the wrinkles of the neck.

Interventions

  • DEVICE SkinPen Precision

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2019-01-31
Est. Completion 2020-01-10
Phase NA

Sponsor

Bellus Medical

2 total trials

What the Registry Record Tells You About NCT03803059

The ClinicalTrials.gov registry entry for NCT03803059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bellus Medical, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which SkinPen Precision is the first listed.

NCT03803059 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03803059 about?

NCT03803059 is a clinical study titled "Efficacy and Tolerability of SkinPen on Male and Female Subjects' Wrinkles of the Neck". This single-center, the clinical trial is being conducted over the course of 90 days followed by 1-month and 6-month post-treatment visits in order to assess the efficacy and tolerability of the Sponsor's SkinPen device when used by men and women with the wrinkles of the neck.

What is the current status of trial NCT03803059?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-01-31. Estimated completion is 2020-01-10.

What interventions are being tested in trial NCT03803059?

The interventions under investigation include: SkinPen Precision (DEVICE).

Who is sponsoring clinical trial NCT03803059?

This trial is sponsored by Bellus Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.